Depomed undefined was downgraded to hold from buy at Cantor Fitzgerald. $23 price target. The company is facing lower growth expectations, Cantor said.
Fluor (FLR) - Get Free Report was downgraded to neutral from outperform at Credit Suisse. $49 price target. The company will struggle to land major awards in the next several quarters, Credit Suisse said.
Microchip (MCHP) - Get Free Report was upgraded to buy from neutral at Bank of America/Merrill Lynch. $75 price target. Management is executing well and the company has diverse growth opportunities, analysts said.
OneMain (OMF) - Get Free Report was downgraded to underperform from buy at Bank of America/Merrill Lynch. $21 price target. The company offered a lower earnings outlook for the next several quarters, analysts said.
This article was written by a staff member of TheStreet.